On evolutionary biology, inflammation, infection, and the causes of atherosclerosis

Circulation

Volumn 105, Issue 1, 2002, Pages 2-4

  Ridker, P M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; I KAPPA B; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; EDITORIAL; EXERCISE; HEALTH EDUCATION; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; PRIORITY JOURNAL; STROKE; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0036143744     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/circ.105.1.2     Document Type: Editorial

References (28)

1. Insulin resistance and inflammation in an evolutionary perspective: The contribution of cytokine genotype/phenotype to thriftiness
2. Is type II diabetes mellitus a disease of the innate immune system?
3. Atherosclerosis: An inflammatory disease
4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
5. Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis
6. High-sensitivity C-reactive protein: Potential adjunct for global risk
7. Diabetes and cardiovascular disease: The "common soil" hypothesis
8. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
9. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
10. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
11. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
12. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
13. Pravastatin and the development of diabetes mellitus: Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
14. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) investigators
15. Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
16. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
17. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ
18. Impact of infectious burden on extent and long-term prognosis of atherosclerosis
19. Infection and atherosclerosis: Potential roles of pathogen burden and molecular mimicry
20. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
21. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men
22. Chlamydia pneumoniae IgG titres and coronary artery disease: Prospective study and meta-analysis
23. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
24. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the Academic study
25. Secondary prevention antibiotic treatment trials for coronary artery disease
26. Relationship of dental and oral pathology to systemic illness
27. Primary prevention of coronary heart disease in women through diet and lifestyle
28. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women